Titre :
  • Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
Auteur : Eggermont, A ; Suciu, Stefan ; Testori, Alessandro ; Kruit, Wim H ; Marsden, Jeremy ; Punt, Cornelis ; Santinami, M. ; Sales, François ; Schadendorf, Dirk ; Patel, Poulam ; Dummer, Reinhard ; Robert, Caroline ; Keilholz, Ulrich ; Yver, Antoine ; Spatz, Alain
Informations sur la publication : European journal of cancer, 48, 2, (page 218-225)
Statut de publication : Publié, 2012-01
Sujet CREF : Cancérologie
Mots-clés MeSH : Antineoplastic Agents -- therapeutic use
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Disease-Free Survival
Epidemiologic Methods
Female
Humans
Immunologic Factors -- administration & dosage
Interferon-alpha -- administration & dosage
Male
Melanoma -- drug therapy -- mortality -- pathology
Neoplasm Staging
Polyethylene Glycols -- administration & dosage
Predictive Value of Tests
Randomized Controlled Trials as Topic
Recombinant Proteins -- administration & dosage
Skin Neoplasms -- drug therapy -- mortality -- pathology
Ulcer -- pathology
Note : Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2011.09.028
info:pii/S0959-8049(11)00787-8
info:pmid/22056637